Mankind Pharma Ltd Sees Surge in Call Options with 10,997 Contracts at Rs 2,700 Strike

Mankind Pharma Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has emerged as one of the most active stocks today. The company’s underlying stock, MANKIND, has seen significant trading activity, particularly in call options set to expire on July 31, 2025. A total of 10,997 contracts were traded at a strike price of Rs 2,700, resulting in a turnover of approximately Rs 1,741.68 lakhs. The open interest stands at 1,366 contracts, indicating ongoing interest in this option.
In terms of price performance, Mankind Pharma has outperformed its sector by 3.37%, marking a notable trend with consecutive gains over the past five days, yielding a total return of 11.53%. Despite opening the day with a loss of 2.28%, the stock rebounded to reach an intraday high of Rs 2,698.20, reflecting a 4.65% increase from its previous close. The stock's intraday low was recorded at Rs 2,519.60.

Mankind Pharma is currently trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, showcasing a strong upward trend. Additionally, the stock has seen a significant rise in delivery volume, with 889,000 shares delivered on July 11, up 101.47% compared to the 5-day average. With a market capitalization of Rs 1,10,995.14 crore, Mankind Pharma continues to demonstrate robust liquidity, supporting a trade size of Rs 6.17 crore. Overall, the activity surrounding Mankind Pharma reflects a dynamic trading environment, underscoring its position in the market.